Effect of N-DicyclopropylmethyI-amino-2-oxazoline (S-3341) on Antioxidant Status and Nitric Oxide in Hypertensive Patients
- 1 January 1998
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 14 (2) , 89-96
- https://doi.org/10.1185/03007999809113347
Abstract
SummaryDefective endothelium-dependent vascular relaxation has been found in animal models of hypertension and in hypertensive patients. An imbalance due to reduced production of nitric oxide (NO) or increased production of free radicals, mainly the superoxide anion, may facilitate the development of an arterial functional spasm. Although it has been shown that many antihypertensive drugs can normalise both the antioxidant activity and NO, the antioxidant effect of N-dicyclopropylmethyl-amino-2-oxazoline (S-3341), an a-adrenoreceptor agonist, has not been investigated. In this study we investigated the antioxidant and NO status in hypertensive patients and whether there was any effect of S-3341 on these parameters.Eleven patients with mild hypertension (mean systolic blood pressure 159.5 ± 2.5 mm Hg) were administered S-3341 (1 mg/day)for 4 weeks. Plasma vitamin E, nitrite-nitrate and MDA levels, and catalase activity, were measured both before and after treatment with S-3341. There was signijicant reduct...Keywords
This publication has 30 references indexed in Scilit:
- Beneficial actions of nitrates in cardiovascular diseaseThe American Journal of Cardiology, 1996
- Antihypertensive Therapy Prevents Endothelial Dysfunction in Chronic Nitric Oxide DeficiencyHypertension, 1996
- Relationship between elevated lipid peroxides, vitamin E deficiency and hypertension in preeclampsiaMolecular and Cellular Biochemistry, 1995
- Involvement of imidazoline-preferring receptors in regulation of sympathetic toneThe American Journal of Cardiology, 1994
- Role of superoxide anions in the mediation of endothelium-dependent contractions.Hypertension, 1994
- Sites of action of alpha2 agonists and antagonistsThe American Journal of Cardiology, 1988
- Pharmacology of the alpha2-adrenoceptor agonist rilmenidineThe American Journal of Cardiology, 1988
- Advantages and disadvantages of alpha2-adrenoceptor agonists for systemic hypertensionThe American Journal of Cardiology, 1988
- The loss of endothelium-dependent vascular relaxation in hypertension.Hypertension, 1986
- Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.Hypertension, 1986